AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
Nkarta, a clinical-stage biopharmaceutical company, will participate in two investor conferences in November: the Stifel 2025 Healthcare Conference and TD Cowen's Immunology & Inflammation Summit. The company will present via fireside chats on November 12 and 13. A webcast of the events will be available on Nkarta's website. The company is developing engineered natural killer cell therapies for autoimmune diseases.

Daily stocks & crypto headlines, free to your inbox
Comments
No comments yet